Assessment of Oral Mucositis in High-Dose Chemotherapy Patients: A Multicenter Evaluation of Interrater Reliability Between Specialized Dentists and Registered Nurses - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Assessment of Oral Mucositis in High-Dose Chemotherapy Patients: A Multicenter Evaluation of Interrater Reliability Between Specialized Dentists and Registered Nurses

  • By

  • Aram Ibrahim

  • Dilav Mahmoud

  • Hanna Mavandadipur

  • Java Walladbegi

  • December 17, 2025

Share

  • 1

    Oral mucositis affects up to 80% of patients receiving high-dose chemotherapy prior to hematopoietic stem cell transplantation.

  • 2

    The World Health Organization oral toxicity scale is commonly used for assessing the severity of oral mucositis.

  • 3

    This study evaluates interrater reliability in oral mucositis assessments between specialized dentists and registered nurses.

  • 4

    Moderate reliability was found in assessments by dental staff, with an intraclass correlation coefficient of 0.672.

  • 5

    Patients were assessed for oral mucositis three times weekly until discharge or resolution, capturing critical mucosal damage phases.

Original Source(s)

Assessment of Oral Mucositis in High-Dose Chemotherapy Patients: A Multicenter Evaluation of Interrater Reliability Between Specialized Dentists and Registered Nurses

  • by Aram Ibrahim, Dilav Mahmoud, Hanna Mavandadipur, Java Walladbegi

  • December 17, 2025

Related Content

The Secrets of the Gut

Going beyond the gut: why microbiome testing is the next big thing in drug development

Impact of multi-channel follow-up as continuous nursing on cancer pain control, adverse reactions, and quality of life in patients with digestive tract tumors: a controlled study of 136 cases

Editorial: Metabolite-induced metabolic reprogramming in the immune system